Search details
1.
Mortality and comorbidities in a Nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults' cohort, France, 2006-18.
Eur J Public Health
; 2024 Feb 26.
Article
in English
| MEDLINE | ID: mdl-38409963
2.
Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018.
Clin Infect Dis
; 76(8): 1364-1371, 2023 04 17.
Article
in English
| MEDLINE | ID: mdl-36527700
3.
Changer de focale pour agir sur une épidémie transfrontalière. Le VIH à la frontière franco-suisse.
Sante Publique
; 33(2): 295-299, 2021.
Article
in French
| MEDLINE | ID: mdl-34553874
4.
Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017.
Euro Surveill
; 22(48)2017 Nov.
Article
in English
| MEDLINE | ID: mdl-29208161
5.
Searching for biomarkers of comorbidities in sera of treated HIV-infected patients by isoelectric focusing.
Electrophoresis
; 36(11-12): 1251-5, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25630581
6.
Serum hepcidin levels in women infected with HIV-1 under antiviral therapy.
J Med Virol
; 86(10): 1656-60, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25043284
7.
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.
BMC Infect Dis
; 14: 150, 2014 Mar 20.
Article
in English
| MEDLINE | ID: mdl-24650094
8.
Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients.
Antimicrob Agents Chemother
; 57(1): 517-23, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23147727
9.
First presentation for care of HIV-infected patients with low CD4 cell count in Lyon, France: risk factors and consequences for survival.
AIDS Care
; 24(10): 1272-6, 2012.
Article
in English
| MEDLINE | ID: mdl-22416893
10.
Soluble chemokine receptor CXCR4 is present in human sera.
Anal Biochem
; 414(2): 202-7, 2011 Jul 15.
Article
in English
| MEDLINE | ID: mdl-21440527
11.
Population pharmacokinetics of tenofovir in AIDS patients.
J Clin Pharmacol
; 48(11): 1282-8, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18779377
12.
Hyperglycosylated ferritin in sera of HIV-1-infected patients treated with highly active antiretroviral therapy.
AIDS
; 20(3): 457-9, 2006 Feb 14.
Article
in English
| MEDLINE | ID: mdl-16439882
13.
Detection of thyroglobulin in antithyroglobulin antibody-positive sera by isoelectric focusing.
Clin Chim Acta
; 447: 39-42, 2015 Jul 20.
Article
in English
| MEDLINE | ID: mdl-25998693
14.
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients.
Clin Infect Dis
; 39(4): 591-4, 2004 Aug 15.
Article
in English
| MEDLINE | ID: mdl-15356829
15.
Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
Antivir Ther
; 8(2): 163-71, 2003 Apr.
Article
in English
| MEDLINE | ID: mdl-12741629
16.
Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study.
HIV Clin Trials
; 4(1): 37-43, 2003.
Article
in English
| MEDLINE | ID: mdl-12577195
17.
Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label study.
Clin Ther
; 33(9): 1308-20, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21872931
18.
Detection of AMP-activated protein kinase in human sera by immuno-isoelectric focusing.
J Immunol Methods
; 351(1-2): 24-9, 2009 Dec 31.
Article
in English
| MEDLINE | ID: mdl-19818790
19.
Depletion in antibodies targeted to the HR2 region of HIV-1 glycoprotein gp41 in sera of HIV-1-seropositive patients treated with T20.
J Acquir Immune Defic Syndr
; 38(3): 254-62, 2005 Mar 01.
Article
in English
| MEDLINE | ID: mdl-15735441
20.
Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial.
J Acquir Immune Defic Syndr
; 40(3): 307-16, 2005 Nov 01.
Article
in English
| MEDLINE | ID: mdl-16249705